U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C23H15Cl4FN2O3S2
Molecular Weight 592.317
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 1
Charge 0

SHOW SMILES / InChI
Structure of DG-041

SMILES

CC1=CN(CC2=CC=C(Cl)C=C2Cl)C3=C1C=C(F)C=C3\C=C\C(=O)NS(=O)(=O)C4=CC(Cl)=C(Cl)S4

InChI

InChIKey=BFBTVZNKWXWKNZ-HWKANZROSA-N
InChI=1S/C23H15Cl4FN2O3S2/c1-12-10-30(11-14-2-4-15(24)7-18(14)25)22-13(6-16(28)8-17(12)22)3-5-20(31)29-35(32,33)21-9-19(26)23(27)34-21/h2-10H,11H2,1H3,(H,29,31)/b5-3+

HIDE SMILES / InChI

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Target ID: P43115|||Q16546
Gene ID: 5733.0
Gene Symbol: PTGER3
Target Organism: Homo sapiens (Human)
4.6 nM [IC50]
PubMed

PubMed

TitleDatePubMed
Patents
Name Type Language
DG-041
Common Name English
2-PROPENAMIDE, 3-(1-((2,4-DICHLOROPHENYL)METHYL)-5-FLUORO-3-METHYL-1H-INDOL-7-YL)-N-((4,5-DICHLORO-2-THIENYL)SULFONYL)-, (2E)-
Systematic Name English
Code System Code Type Description
CAS
1030374-84-5
Created by admin on Sat Dec 16 08:25:35 GMT 2023 , Edited by admin on Sat Dec 16 08:25:35 GMT 2023
SUPERSEDED
PUBCHEM
11296282
Created by admin on Sat Dec 16 08:25:35 GMT 2023 , Edited by admin on Sat Dec 16 08:25:35 GMT 2023
PRIMARY
FDA UNII
1844425CLP
Created by admin on Sat Dec 16 08:25:35 GMT 2023 , Edited by admin on Sat Dec 16 08:25:35 GMT 2023
PRIMARY
EPA CompTox
DTXSID30722748
Created by admin on Sat Dec 16 08:25:35 GMT 2023 , Edited by admin on Sat Dec 16 08:25:35 GMT 2023
PRIMARY
CAS
861238-35-9
Created by admin on Sat Dec 16 08:25:35 GMT 2023 , Edited by admin on Sat Dec 16 08:25:35 GMT 2023
PRIMARY